Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gottfried

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Scientific Reports|March 23, 2022
Dimensions and forms of artefacts in 1.5 T and 3 T MRI caused by cochlear implantsTimo M Gottfried, Daniel Dejaco, Natalie Fischer, et al.
Magyar Onkologia|September 5, 2015
[Molecular diagnostics of lung cancer]A Ryska, R Dziadziuszko, W Olszewski, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|April 2, 2024
Evaluation of an impedance-based method to monitor the insertion of the electrode array during cochlear implantationTimo M Gottfried, Pablo Galeazzi, Aline Föger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2000
Phase III comparative study of high-dose cisplatin versus a combination of paclitaxel and cisplatin in patients with advanced non-small-cell lung cancerU Gatzemeier, J von Pawel, M Gottfried, et al.
Bone Marrow Transplantation|April 15, 2003
Adjuvant treatment of high-risk stage II breast cancer with doxorubicin followed by high-dose chemotherapy and autologous stem-cell transplantation: a single-institution experience with 132 consecutive patientsS M Stemmer, I Hardan, H Raz, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 1996
Activity of gemcitabine in patients with non-small cell lung cancer: a multicentre, extended phase II studyU Gatzemeier, F A Shepherd, T Le Chevalier, et al.
Bulletin Du Cancer|March 1, 1997
[A phase II multicenter study of gemcitabine in non small cell lung cancers]T Le Chevalier, M Gottfried, U Gatzemeier, et al.
Prostate Cancer and Prostatic Diseases|March 1, 2017
Imaging response during therapy with radium-223 for castration-resistant prostate cancer with bone metastases-analysis of an international multicenter databaseD Keizman, M O Fosboel, H Reichegger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2022
Pembrolizumab in microsatellite instability high or mismatch repair deficient cancers: updated analysis from the phase II KEYNOTE-158 studyM Maio, P A Ascierto, L Manzyuk, et al.
Bulletin Du Cancer|May 1, 1996
[Results of a randomized study comparing combination of navelbine-cisplatin to combination of vindesine-cisplatin and to navelbine alone in 612 patients with inoperable non-small cell lung cancer]T Le Chevalier, D Brisgand, J L Pujol, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Scientific Reports|March 23, 2022
Dimensions and forms of artefacts in 1.5 T and 3 T MRI caused by cochlear implantsTimo M Gottfried, Daniel Dejaco, Natalie Fischer, et al.
Magyar Onkologia|September 5, 2015
[Molecular diagnostics of lung cancer]A Ryska, R Dziadziuszko, W Olszewski, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|April 2, 2024
Evaluation of an impedance-based method to monitor the insertion of the electrode array during cochlear implantationTimo M Gottfried, Pablo Galeazzi, Aline Föger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2000
Phase III comparative study of high-dose cisplatin versus a combination of paclitaxel and cisplatin in patients with advanced non-small-cell lung cancerU Gatzemeier, J von Pawel, M Gottfried, et al.
Bone Marrow Transplantation|April 15, 2003
Adjuvant treatment of high-risk stage II breast cancer with doxorubicin followed by high-dose chemotherapy and autologous stem-cell transplantation: a single-institution experience with 132 consecutive patientsS M Stemmer, I Hardan, H Raz, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 1996
Activity of gemcitabine in patients with non-small cell lung cancer: a multicentre, extended phase II studyU Gatzemeier, F A Shepherd, T Le Chevalier, et al.
Bulletin Du Cancer|March 1, 1997
[A phase II multicenter study of gemcitabine in non small cell lung cancers]T Le Chevalier, M Gottfried, U Gatzemeier, et al.
Prostate Cancer and Prostatic Diseases|March 1, 2017
Imaging response during therapy with radium-223 for castration-resistant prostate cancer with bone metastases-analysis of an international multicenter databaseD Keizman, M O Fosboel, H Reichegger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2022
Pembrolizumab in microsatellite instability high or mismatch repair deficient cancers: updated analysis from the phase II KEYNOTE-158 studyM Maio, P A Ascierto, L Manzyuk, et al.
Bulletin Du Cancer|May 1, 1996
[Results of a randomized study comparing combination of navelbine-cisplatin to combination of vindesine-cisplatin and to navelbine alone in 612 patients with inoperable non-small cell lung cancer]T Le Chevalier, D Brisgand, J L Pujol, et al.
Pageof 4